These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8688539)

  • 21. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
    Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
    Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of platelet behaviour by isosorbide dinitrate.
    Dutrillaux F; Lecompte T; Samama M
    Thromb Haemost; 1989 Feb; 61(1):152-3. PubMed ID: 2665166
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of melatonin on thrombocyte aggregation in healthy subjects].
    Evsiukova EV; Petrishchev NN
    Fiziol Cheloveka; 1998; 24(6):122-5. PubMed ID: 9929964
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the effects of cisplatin and cisplatinum (II)phosphonate complex on ADP-induced platelet aggregation in vitro.
    Kostka B; Ochocki J
    Pharmazie; 1996 Dec; 51(12):990-2. PubMed ID: 8985988
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro.
    Herbert JM; Savi P
    Thromb Haemost; 1999 Jul; 82(1):156-7. PubMed ID: 10456476
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events.
    Lahiri P; Chaudhuri U; Chattopadhyay A; Chakraborty P; Mandal D; Dasgupta AK
    Blood Cells Mol Dis; 2005; 34(3):248-56. PubMed ID: 15885609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiplatelet effects of nimodipine: synergism with prostacyclin].
    Catalano I; Davì G; Mogavero A; Spatola A; Belvedere M; Notarbartolo A; Strano A
    Ann Ital Med Int; 1988; 3(4):264-8. PubMed ID: 3152787
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.
    Lopez-Johnston JC; de Bosch N; Scannone H; Rodríguez-Acosta A
    Ann Hematol; 2007 Dec; 86(12):879-85. PubMed ID: 17891398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
    Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
    Nyby MD; Sasaki M; Ideguchi Y; Wynne HE; Hori MT; Berger ME; Golub MS; Brickman AS; Tuck ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):503-9. PubMed ID: 8768697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor analysis of LDL-induced platelet aggregation.
    Vlasova II; Azizova OA; Lopukhin YuM
    Biochemistry (Mosc); 1997 Mar; 62(3):307-11. PubMed ID: 9275303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet activity of inositol hexaphosphate (IP6).
    Vucenik I; Podczasy JJ; Shamsuddin AM
    Anticancer Res; 1999; 19(5A):3689-93. PubMed ID: 10625941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes].
    Petrukhina GN; Makarova VA; FReĭmanis IaF; Lozha EV
    Eksp Klin Farmakol; 1995; 58(6):45-8. PubMed ID: 8704613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
    Rpshchupkin DI; Berzhitskaia VV; Murina MA
    Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.
    Wildemann B; Schülin C; Storch-Hagenlocher B; Hacke W; Dithmar S; Kirchhof K; Jansen O; Breitbart A
    Stroke; 1996 Jan; 27(1):149-51. PubMed ID: 8553395
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of intracellular signaling events in ADP-induced platelet aggregation.
    Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
    Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.